TABLE 4.

Absorbance values from an ELISA after binding of HSV type-specific MAbs and purified human anti-gG-1 antibodies to GMK cells infected with different HSV strains

HSV-1 strains or clinical isolate	Mean absorbance ± SD
	Anti-gG-1 MAb	Purifieda anti-gG-1 antibodies	Anti-gC-1 MAb	Anti-gG-2 MAb
1	1.30 ± 0.16	0.71 ± 0.10	2.34 ± 0.20	0.12 ± 0.01
2	0.90 ± 0.07	0.58 ± 0.06	2.15 ± 0.03	0.12 ± 0.00
3	1.20 ± 0.05	0.54 ± 0.01	2.52 ± 0.09	0.14 ± 0.00
4	1.60 ± 0.10	0.85 ± 0.07	2.86 ± 0.04	0.12 ± 0.02
5	1.20 ± 0.01	0.67 ± 0.07	1.98 ± 0.08	0.13 ± 0.01
6	1.00 ± 0.01	0.70 ± 0.02	2.16 ± 0.17	0.14 ± 0.00
7	0.14 ± 0.01	0.55 ± 0.02	2.10 ± 0.16	0.12 ± 0.01
8	1.60 ± 0.09	0.80 ± 0.11	2.84 ± 0.12	0.13 ± 0.01
9	0.13 ± 0.01	0.60 ± 0.02	2.47 ± 0.09	0.13 ± 0.01
10	1.40 ± 0.02	0.60 ± 0.03	2.63 ± 0.05	0.13 ± 0.01
F	1.30 ± 0.02	0.83 ± 0.12	2.41 ± 0.07	0.12 ± 0.01
KOS 321	0.15 ± 0.01	0.52 ± 0.05	1.85 ± 0.11	0.13 ± 0.01
HSV-2 (333)	0.20 ± 0.01	0.17 ± 0.01	0.12 ± 0.01	2.36 ± 0.20
Uninfected cells	0.10 ± 0.01	0.11 ± 0.01	0.11 ± 0.01	0.11 ± 0.00

^aSerum from patient 5.